Back to search

Article

The Safety of Low-Molecular-Weight Heparin Bridging Therapy in Patients Receiving Preoperative Oral Antithrombotic Drugs During Spinal Fusion Surgery

2026-01-12

Abstract excerpt

<title>Abstract</title> <p> <bold>【Purpose】</bold> To evaluate whether preoperative oral antithrombotic drugs increase perioperative bleeding risk in spinal fusion patients receiving low-molecular-weight-heparin (LMWH) bridging therapy, and compare bleeding risk with general patients. <bold>【Methods】</bold> Patients who underwent spinal fusion (2019–2024) at two hospitals were grouped: Oral Anticoagulation go...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2efe771a-66d3-56e3-9d58-592ce80ac18f
DOI
10.21203/rs.3.rs-8344022/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Safety of Low-Molecular-Weight Heparin Bridging Therapy in Patients Receiving Preoperative Oral Antithrombotic Drugs During Spinal Fusion SurgeryDOI 10.21203/rs.3.rs-8344022/v1
Select a neighboring publication to make it the new centre.